BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

560 related articles for article (PubMed ID: 22419173)

  • 21. [Cartilage regeneration using cell reprogramming technologies].
    Tsumaki N
    Clin Calcium; 2013 Nov; 23(11):1641-8. PubMed ID: 24162605
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epigenetic reprogramming in somatic cells induced by extract from germinal vesicle stage pig oocytes.
    Bui HT; Kwon DN; Kang MH; Oh MH; Park MR; Park WJ; Paik SS; Van Thuan N; Kim JH
    Development; 2012 Dec; 139(23):4330-40. PubMed ID: 23132243
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Stimulus-triggered acquisition of pluripotency: a new perspective in reprogramming of differentiated somatic cells].
    Blum HE
    Dtsch Med Wochenschr; 2014 Feb; 139(9):441-3. PubMed ID: 24557999
    [No Abstract]   [Full Text] [Related]  

  • 24. Reprogrammed induced pluripotent stem cells: how suitable could they be in reproductive medicine?
    Ensenat-Waser R; Pellicer A; Simon C
    Fertil Steril; 2009 Apr; 91(4):971-4. PubMed ID: 19200985
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Future perspective of induced pluripotent stem cells for diagnosis, drug screening and treatment of human diseases.
    Lian Q; Chow Y; Esteban MA; Pei D; Tse HF
    Thromb Haemost; 2010 Jul; 104(1):39-44. PubMed ID: 20539907
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recent progressions in stem cell research: breakthroughs achieved and challenges faced.
    Tani J; Umbas R
    Acta Med Indones; 2009 Jan; 41(1):30-5. PubMed ID: 19258678
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genomic stability in reprogramming.
    Ronen D; Benvenisty N
    Curr Opin Genet Dev; 2012 Oct; 22(5):444-9. PubMed ID: 23040504
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An introduction to induced pluripotent stem cells.
    Hanley J; Rastegarlari G; Nathwani AC
    Br J Haematol; 2010 Oct; 151(1):16-24. PubMed ID: 20666774
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of reprogramming genes in induced pluripotent stem cells and nuclear transfer cloned embryos.
    Duan L; Wang Z; Shen J; Shan Z; Shen X; Wu Y; Sun R; Li T; Yuan R; Zhao Q; Bai G; Gu Y; Jin L; Lei L
    Stem Cell Rev Rep; 2014 Aug; 10(4):548-60. PubMed ID: 24828831
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oct4 and klf4 reprogram dermal papilla cells into induced pluripotent stem cells.
    Tsai SY; Clavel C; Kim S; Ang YS; Grisanti L; Lee DF; Kelley K; Rendl M
    Stem Cells; 2010 Feb; 28(2):221-8. PubMed ID: 20014278
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dedifferentiation, transdifferentiation, and reprogramming: future directions in regenerative medicine.
    Eguizabal C; Montserrat N; Veiga A; Izpisua Belmonte JC
    Semin Reprod Med; 2013 Jan; 31(1):82-94. PubMed ID: 23329641
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Emerging methods for preparing iPS cells.
    Miyazaki S; Yamamoto H; Miyoshi N; Takahashi H; Suzuki Y; Haraguchi N; Ishii H; Doki Y; Mori M
    Jpn J Clin Oncol; 2012 Sep; 42(9):773-9. PubMed ID: 22826352
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Induced pluripotent stem cells: progress and future perspectives in the stem cell world.
    Rezanejad H; Matin MM
    Cell Reprogram; 2012 Dec; 14(6):459-70. PubMed ID: 23035654
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Generation of induced pluripotent stem cells from somatic cells.
    Sohn YD; Han JW; Yoon YS
    Prog Mol Biol Transl Sci; 2012; 111():1-26. PubMed ID: 22917224
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of MEF feeder cells in direct reprogramming of mousetail-tip fibroblasts.
    Chen M; Sun X; Jiang R; Shen W; Zhong X; Liu B; Qi Y; Huang B; Xiang AP; Ge J
    Cell Biol Int; 2009 Dec; 33(12):1268-73. PubMed ID: 19524692
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Ethical reflections on cell reprogramming].
    Aznar Lucea J; Martínez M
    Cuad Bioet; 2012; 23(78):287-99. PubMed ID: 23130744
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evolution of induced pluripotent stem cell technology.
    Zhou H; Ding S
    Curr Opin Hematol; 2010 Jul; 17(4):276-80. PubMed ID: 20442654
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Veterinary applications of induced pluripotent stem cells: regenerative medicine and models for disease?
    Cebrian-Serrano A; Stout T; Dinnyes A
    Vet J; 2013 Oct; 198(1):34-42. PubMed ID: 24129109
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of leukaemia inhibitory factor in the induction of pluripotent stem cells in mice.
    Xu J; Wang F; Tang Z; Zhan Y; Zhang J; Yan Q; Xiong Y; Xie X; Wu J; Zhang S
    Cell Biol Int; 2010 Aug; 34(8):791-7. PubMed ID: 20392203
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dedifferentiation of cells: new approaches.
    Collas P
    Cytotherapy; 2007; 9(3):236-44. PubMed ID: 17464755
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.